Immunosuppression and transplant vascular disease: benefits and adverse effects

This publication has 93 references indexed in Scilit:

• PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
  Nature, 2000
• TRANSFORMING GROWTH FACTOR (TGF)-?? MIMICS AND ANTI-TGF-?? ANTIBODY ABROGATES THE IN VIVO EFFECTS OF CYCLOSPORINE
  Transplantation, 1999
• New Perspectives on PKCθ, a Member of the Novel Subfamily of Protein Kinase C
  The International Journal of Cell Cloning, 1998
• PHARMACOLOGICALLY INDUCED REGRESSION OF CHRONIC TRANSPLANT REJECTION
  Transplantation, 1995
• CALCINEURIN ACTIVITY IS ONLY PARTIALLY INHIBITED IN LEUKOCYTES OF CYCLOSPORINE-TREATED PATIENTS
  Transplantation, 1995
• Cardiac allograft vasculopathy: Current concepts
  American Heart Journal, 1995
• Angiopeptin (BIM23014C) Inhibits Vascular Smooth Muscle Cell Migration In Vitro Through a G-Protein-Mediated Pathway and Is Associated with Inhibition of Adenylyl Cyclase and Cyclic AMP Accumulation
  Journal of Cardiovascular Pharmacology, 1995
• Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression
  Cell, 1993
• The role of cytochromes P-450 in cyclosporine metabolism
  Journal of the American Academy of Dermatology, 1990
• Cyclosporine
  New England Journal of Medicine, 1989